Trump Is Not Legalizing Drugs — He Is Repricing Americans

This executive order is not drug policy. It is a fiscal reclassification of human lifetime value (LTV).

On December 18, 2025, the Trump administration reclassified marijuana from Schedule I to Schedule III. This did not move the substance toward freedom. It moved it from criminal law into the accounting systems of insurance, pharmaceuticals, and medicine. Allowing Medicare to reimburse CBD-based treatments formally enrolled cancer patients and the elderly as revenue-generating clients of the state. Marijuana was not released. It was entered into the national ledger.

The United States has shifted from a credit society to a value (LTV) society.

In the past, citizenship was evaluated by whether someone paid their debts. Today, it is evaluated by whether someone generates lifetime fiscal value. Marijuana patients, the elderly, and the chronically ill are now high-LTV assets, producing insurance claims, prescriptions, drug revenue, and research funding. Transgender minors, the homeless, and the disabled are classified as low-LTV populations, generating cost, controversy, and political risk. This distinction is not moral. It is accounting.

Insurance has become the modern form of excommunication.

Cutting Medicare and Medicaid coverage for transgender care is not a ban. It is a denial of payment. In a modern system, being removed from insurance means being rejected by hospitals, doctors, and pharmacies simultaneously. The state can then say: “We did not prohibit anything. It simply was not profitable.” This is governance through strategic abdication of responsibility.

Risk is outsourced while revenue is centralized.

The removal of transgender education from Texas medical schools and the weakening of syringe-exchange programs follow the same logic. These bodies have been reclassified as assets unworthy of insurance coverage. The resulting costs — infection, suicide, underground treatment — are pushed onto families and local communities. Meanwhile, the marijuana industry is absorbed into a federally protected revenue ecosystem.

AI is the machine that assigns human price tags, and data is the new bloodline.

Trump’s AI executive order weakens state-level rules on algorithmic discrimination and transparency in favor of federal control. This is not simply corporate protection. It is the centralization of the power to decide who is economically valuable — across credit, employment, insurance, healthcare, and policing. In this system, data becomes an irreversible digital caste mark. In the past, identities could be laundered. In an algorithmic value society, data becomes destiny.

In this system, resistance disappears — only denials remain.

Laws can be challenged. Courts can be fought. But algorithmic rejection and insurance denial have no visible opponent. Power is no longer exercised through verdicts but through the word “Denied” on a screen. Citizens are no longer voters. They are subscribers.

Trump is not legalizing drugs. He is repricing Americans.

One question remains.
Are you a profit or a cost to this system?
Before it assigns you a price, what defenses do you have?

3-Line Summary

  • The United States is shifting from credit-based citizenship to lifetime-value citizenship.
  • Insurance systems and AI now execute this repricing, while data becomes a permanent class marker.
  • Governance is no longer exercised through law, but through denial and algorithmic judgment.

Reference

This article is based on publicly available news content collected through the GDELT Global Knowledge Graph (GKG).
Tone metrics, metadata, and semantic clusters were processed using Infowider’s internal analysis pipeline.
No information beyond what is contained in the original articles has been added.

Trending now

Uvalde Police Acquittal: The Court Ruled That Hesitation Is Not a Crime
Trump Is Not Legalizing Drugs — He Is Repricing Americans
The Kremlin Is Not Negotiating Peace — It Is Trading Silence
Why Your Costs Are Rising — Even If You’ve Never Heard of Somaliland